A first-in-human trial of intravesical BH011, a novel docetaxel formulation, in patients with high risk non-muscle invasive bladder cancer (HR-NMIBC) after BCG failure: Results from a phase 1 study.
Recognition of the need to restore degraded landscapes is accelerating at pace. The UN Decade on Ecosystem Restoration (the UN Decade) has triggered a global movement to rally individual action, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results